FindTrial
Sign In

Study 1 - Therapeutic and Ergogenic effects of the Regional Herb Tereré on exercise tolerance in well-trained female runners

Therapeutic and Ergogenic effects of a Regional Extract: TERERÉ

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8d4r7gv
Enrollment
Unknown
Registered
2025-11-25
Start date
2026-01-05
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Running

Interventions

This is a randomized, double-blind, crossover clinical trial. The present study includes female runners (n = 50) as the sample, and the adopted procedures involve the application of tests that are wid

Sponsors

Universidade Federal de Mato Grosso do Sul
Lead Sponsor
Universidade Federal de Mato Grosso do Sul
Collaborator

Eligibility

Sex/Gender
Female
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Well-trained competitive or recreational female runners; experienced in endurance; healthy; aged 16 years or older; active in the modality for at least 3 years; engaged in regular endurance training (at least 4 times per week); and with familiarity in road races of at least 10,000 m

Exclusion criteria

Exclusion criteria: Presenting injuries during the study period; experiencing adverse effects from caffeine consumption; reporting cardiovascular diseases or chronic non-communicable diseases (NCDs) and any other health conditions; use of medications for cardiac, pulmonary, thyroid, antihypertensive, endocrinological, or neuromuscular conditions

Design outcomes

Primary

MeasureTime frame
Performance will be assessed through time to complete the test, expressed in minutes and seconds.—

Secondary

MeasureTime frame
The Borg Rating of Perceived Exertion scale (6–20) to report their perceived effort during the trial. Flow assessment using the Flow State Scale (FSS-2), aimed at expressing how the participant experienced the session.;The heart rate (HR, Bpm) and will be used as exhaustion criteria.;Blood samples will be collected upon arrival at the laboratory and 45 minutes after ingestion of the experimental condition, before the exercise session, to determine plasma caffeine levels and verify absorption of the compound present in tereré.;Absolute values of systolic and diastolic blood pressure (mmHg) at predefined recovery times (5 minutes post-exercise)—

Countries

Brazil

Contacts

Public ContactRaquel Barizon

Universidade Federal de Mato Grosso do Sul

raquel.rossignoli@ufms.br+55-67-33457630

Outcome results

None listed

Source: REBEC (via WHO ICTRP)